We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
-9.43%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
AUM
$2.7B
AUM Growth
-$296M
Cap. Flow
+$44.6M
Cap. Flow %
1.65%
Top 10 Hldgs %
8.27%
Holding
1,895
New
457
Increased
377
Reduced
454
Closed
575

Top Sells

Rank Stock Value
1
COR icon
Cencora
COR
+$22.3M
2
AMGN icon
Amgen
AMGN
+$21.9M
3
BABA icon
Alibaba
BABA
+$18.9M
4
SLB icon
SLB Ltd
SLB
+$18M
5
BMY icon
Bristol-Myers Squibb
BMY
+$14.8M

Sector Composition

Rank Sector Weight
1 Healthcare 13.76%
2 Technology 13.33%
3 Consumer Discretionary 12.45%
4 Industrials 11.02%
5 Financials 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANAC
151
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$4.58M 0.17%
38,909
-30,331
-44% -$3.96M
BXLT
152
DELISTED
BAXALTA INC COM STK (DE)
BXLT
$4.56M 0.17%
+144,839
New +$5M
CPA icon
153
Copa Holdings
CPA
$5.57B
$4.56M 0.17%
+108,796
New +$6.86M
BXP icon
154
Boston Properties
BXP
$11.1B
$4.55M 0.17%
+38,455
New +$4.6M
MNDT
155
DELISTED
Mandiant, Inc. Common Stock
MNDT
$4.54M 0.17%
+142,691
New +$5.95M
ARMH
156
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$4.5M 0.17%
104,015
+93,770
+915% +$4.18M
DRE
157
DELISTED
Duke Realty Corp.
DRE
$4.48M 0.17%
235,090
+93,609
+66% +$1.79M
CSX icon
158
CSX Corp
CSX
$97.1B
$4.42M 0.16%
+492,708
New +$4.83M
BMR
159
DELISTED
BIOMED REALTY TRUST INC
BMR
$4.41M 0.16%
220,945
+76,200
+53% +$1.52M
BRCM
160
DELISTED
BROADCOM CORP CL-A
BRCM
$4.41M 0.16%
85,800
-122,204
-59% -$6.29M
BBY icon
161
Best Buy
BBY
$18.4B
$4.38M 0.16%
118,078
-308,913
-72% -$10.6M
CP icon
162
Canadian Pacific Kansas City
CP
$81.4B
$4.37M 0.16%
152,055
+6,345
+4% +$191K
CENX icon
163
Century Aluminum
CENX
$4.42B
$4.35M 0.16%
946,092
+343,417
+57% +$2.4M
GIS icon
164
General Mills
GIS
$19.5B
$4.33M 0.16%
+77,143
New +$4.42M
STNG icon
165
Scorpio Tankers
STNG
$3.87B
$4.32M 0.16%
47,141
+8,018
+20% +$803K
NBIX icon
166
Neurocrine Biosciences
NBIX
$17.9B
$4.3M 0.16%
108,205
+52,633
+95% +$2.54M
MSTR icon
167
Strategy Inc
MSTR
$35.3B
$4.3M 0.16%
219,020
-25,270
-10% -$501K
LRCX icon
168
Lam Research
LRCX
$359B
$4.29M 0.16%
657,200
+172,180
+35% +$1.26M
PPLI
169
People Inc
PPLI
$3.12B
$4.29M 0.16%
+367,926
New +$4.89M
JCI icon
170
Johnson Controls International
JCI
$86.7B
$4.28M 0.16%
98,757
-91,930
-48% -$4.24M
BAP icon
171
Credicorp
BAP
$30.6B
$4.27M 0.16%
40,193
+29,083
+262% +$3.52M
PANW icon
172
Palo Alto Networks
PANW
$265B
$4.25M 0.16%
+148,428
New +$4.38M
ENOV icon
173
Enovis
ENOV
$1.61B
$4.25M 0.16%
82,548
+72,597
+730% +$4.82M
VAR
174
DELISTED
Varian Medical Systems, Inc.
VAR
$4.21M 0.16%
+65,037
New +$4.74M
DYN
175
DELISTED
Dynegy, Inc.
DYN
$4.18M 0.15%
+202,106
New +$5.13M

Similar funds

A.R.T. Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, A.R.T. Advisors held 1,895 positions worth $2.7B, down 9.9% from $3B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

A.R.T. Advisors's Q3 2015 filing shows 457 new, 377 increased, 454 reduced and 575 closed positions. Its largest new stake was Teva Pharmaceuticals: 414,963 shares worth $23.4M. The largest sale was Cencora, an estimated $22.3M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.

  • A.R.T. Advisors's largest Q3 2015 buy was Teva Pharmaceuticals: 414,963 shares worth $23.4M.
  • A.R.T. Advisors added most to Alphabet (Google) Class C in Q3 2015, an estimated $24.9M increase.
  • A.R.T. Advisors's biggest Q3 2015 reduction was Cencora, cutting an estimated $22.3M.
  • A.R.T. Advisors fully exited Alibaba in Q3 2015, selling an estimated $18.9M.
  • A.R.T. Advisors's ten largest holdings make up 8.3% of its $2.7B portfolio in Q3 2015.
  • A.R.T. Advisors opened 457 new positions and closed 575 in Q3 2015.
  • A.R.T. Advisors's portfolio value fell 9.9% quarter-over-quarter to $2.7B.

Based on A.R.T. Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.